Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
Molecular Weight:
145 kDa
Purity:
99.30%
CAS Number:
[1380723-44-3]
Target:
Apoptosis|||PD-1/PD-L1|||Autophagy
T9902
* VAT and and shipping costs not included. Errors and price changes excepted
